Keyes Stange & Wooten Wealth Management LLC decreased its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 53.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 651 shares of the healthcare conglomerate's stock after selling 757 shares during the quarter. Keyes Stange & Wooten Wealth Management LLC's holdings in UnitedHealth Group were worth $329,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also made changes to their positions in UNH. Howard Capital Management Group LLC bought a new stake in UnitedHealth Group in the third quarter valued at about $341,000. Principal Financial Group Inc. lifted its position in shares of UnitedHealth Group by 11.3% in the 3rd quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate's stock worth $1,039,933,000 after buying an additional 180,479 shares during the last quarter. M&T Bank Corp raised its stake in UnitedHealth Group by 13.4% during the third quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate's stock worth $128,975,000 after acquiring an additional 26,074 shares during the period. McIlrath & Eck LLC boosted its stake in UnitedHealth Group by 8.2% in the third quarter. McIlrath & Eck LLC now owns 635 shares of the healthcare conglomerate's stock valued at $371,000 after acquiring an additional 48 shares during the period. Finally, SOA Wealth Advisors LLC. lifted its stake in UnitedHealth Group by 3.7% in the third quarter. SOA Wealth Advisors LLC. now owns 1,275 shares of the healthcare conglomerate's stock valued at $746,000 after buying an additional 46 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.
UnitedHealth Group Stock Down 2.2 %
Shares of UNH traded down $13.24 during trading hours on Monday, hitting $586.23. 4,838,165 shares of the company were exchanged, compared to its average volume of 4,346,637. The firm's 50 day moving average is $512.87 and its 200-day moving average is $541.80. UnitedHealth Group Incorporated has a 52 week low of $438.50 and a 52 week high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The company has a market cap of $536.23 billion, a PE ratio of 37.82, a PEG ratio of 1.37 and a beta of 0.61.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business's quarterly revenue was up 6.8% on a year-over-year basis. During the same quarter last year, the firm posted $5.83 EPS. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were paid a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.43%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's payout ratio is currently 54.19%.
Analyst Ratings Changes
A number of research analysts have issued reports on the stock. Cantor Fitzgerald reissued an "overweight" rating and set a $700.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. HSBC raised UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 target price on the stock in a research note on Friday, January 10th. Hsbc Global Res raised UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research note on Friday, January 10th. StockNews.com upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research report on Thursday, January 23rd. Finally, Mizuho increased their target price on shares of UnitedHealth Group from $600.00 to $650.00 and gave the company an "outperform" rating in a research note on Wednesday, April 9th. Twenty-one research analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Buy" and a consensus price target of $632.85.
Read Our Latest Analysis on UNH
Insider Transactions at UnitedHealth Group
In related news, Director Timothy Patrick Flynn bought 1,000 shares of the business's stock in a transaction that occurred on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now directly owns 4,500 shares of the company's stock, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders own 0.33% of the company's stock.
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
